AI-Integrated Emotional Granularity Training for Resilience and Quality of Life in Colorectal Cancer Survivors
Development and Evaluation of an AI-Integrated Emotional Granularity Growth (AI-EGG) on Enhancing Resilience and Improving Quality of Life in Young and Middle-Aged Colorectal Cancer Survivors
The goal of this clinical trial is to evaluate an AI-integrated Emotional Granularity Growth intervention (AI-EGG) designed to enhance resilience and improve quality of life in young and middle-aged colorectal cancer (CRC) survivors. Emotional granularity refers to the ability to clearly identify and differentiate subtle emotional experiences, which may help individuals regulate emotions more effectively and build resilience after cancer treatment.
The main questions it aims to answer are:
- Does the AI-EGG intervention improve resilience in CRC survivors compared with routine psychological care?
- Does the intervention improve emotional granularity, emotion regulation ability, and quality of life?
- Is the AI-EGG intervention feasible and acceptable for young and middle-aged CRC survivors?
Researchers will compare the AI-EGG intervention group to a control group receiving routine psychological care and standard educational materials to see whether the intervention leads to better psychological outcomes.
Participants will:
- Complete baseline assessments measuring emotional granularity, emotion regulation, resilience, and quality of life
- Be randomly assigned to either the intervention group or the control group
- In the intervention group, engage in a 4-week AI chatbot-based program focusing on emotional identification, differentiation, regulation, and reflective practice (at least two sessions per week)
- In the control group, receive routine psychological care and standard educational materials
- Complete post-intervention assessments immediately after the 4-week program and again at a 1-month follow-up
- Some participants in the intervention group will be invited to complete interviews about their experience of the program
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study is a randomized controlled trial designed to evaluate the feasibility, acceptability, and preliminary effectiveness of an AI-integrated Emotional Granularity Growth intervention (AI-EGG) in improving resilience, quality of life emotional granularity and emotion regulation among young and middle-aged colorectal cancer (CRC) survivors.
CRC survivors in early and middle adulthood often experience persistent psychological adaptation difficulties after completion of primary treatment, even when clinical disease is stable. These difficulties include reduced resilience, impaired emotion regulation, and decreased quality of life. Emotional processes are considered central to post-treatment psychological adaptation, and resilience is conceptualized as a key psychosocial outcome reflecting individuals' ability to adapt to cancer-related adversity.
Emotion regulation is an important determinant of resilience; however, existing interventions typically focus on general emotion regulation strategies without directly targeting the individual's ability to differentiate and label emotional experiences. Emotional granularity, defined as the ability to distinguish and accurately label discrete emotional states, is proposed as a cognitive-affective mechanism that may enhance emotion regulation effectiveness and thereby support resilience.
The AI-EGG intervention is developed based on this theoretical framework and is delivered via an online chatbot platform. The intervention is structured as a 4-week program that provides guided, interactive training in emotional granularity. The chatbot system delivers standardized yet interactive modules focusing on emotional identification, emotional differentiation, emotion regulation, and reflective emotional processing. Participants are encouraged to engage with the system at least twice per week, with additional voluntary engagement supported by the platform.
The study adopts a parallel-group randomized controlled design. Participants are randomly assigned to either the AI-EGG intervention group or a control group receiving routine psychological care and standard educational materials. The intervention is delivered remotely through a mobile-based chatbot system, enabling flexible and repeated engagement in real-life contexts.
Outcome assessments are conducted at baseline, immediately after the 4-week intervention period, and at 1-month follow-up. These assessments evaluate changes in emotional granularity, emotion regulation, resilience, and quality of life over time.
In addition to quantitative evaluation, a qualitative component is conducted among a purposively selected subset of participants in the intervention group. Semi-structured interviews are used to explore participants' experiences of using the AI-EGG system, perceived changes in emotional granularity and resilience, engagement patterns, and perceived acceptability of the intervention.
Overall, this study aims to provide preliminary evidence on whether an AI-based emotional granularity training program can improve emotional granularity and support resilience in CRC survivors, and to inform the development of scalable digital psychosocial interventions in oncology care.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Joyce Oi Kwan Chung, PhD
- Número de teléfono: 852-27666322
- Correo electrónico: okjoyce.chung@polyu.edu.hk
Ubicaciones de estudio
-
-
Jiangsu
-
Kunshan, Jiangsu, Porcelana, 215300
- Kunshan First People's Hospital Affiliated to Jiangsu University
-
Contacto:
- Juan Song, MSN
- Número de teléfono: 86-13913274133
- Correo electrónico: 93930739@qq.com
-
Suzhou, Jiangsu, Porcelana, 215000
- The Second Affiliated Hospital of Soochow University
-
Contacto:
- Li Tian, PhD
- Número de teléfono: 86-13862596317
- Correo electrónico: tianlisz@suda.edu.cn
-
Suzhu, Jiangsu, Porcelana, 215000
- The First Affiliated Hospital of Soochow University
-
Contacto:
- Li Tian, PhD
- Número de teléfono: 86-13862596317
- Correo electrónico: tianlisz@suda.edu.cn
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- (1) young and middle-aged adult patients (age in the range of 18-60 years);
- (2) patients diagnosed with CRC;
- (3) patients have completed primary curative-intent treatment for colorectal cancer, and are currently in a stable post-treatment or maintenance phase of care without evidence of active disease progression or acute treatment-related instability;
- (4) patients able to use a smartphone and agree to participate in the study.
Exclusion Criteria:
- (1) patients who have been informed of their cancer diagnosis due to family decision to withhold information;
- (2) patients suffering from severe comorbidities or conditions that may affect participation or assessment, such as significant cognitive impairment (e.g., dementia, severe memory loss), psychiatric disorders, or other serious medical complications;
- (3) those who are participating in other psychological intervention studies.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention group
Participants in the intervention group will receive a 4-week AI-EGG intervention delivered through a digital intervention platform, in addition to routine psychological care.
|
The 4-week Emotional Granularity Growth intervention (AI-EGG) will be delivered via a structured mobile-based digital platform based on emotional granularity theory and Gross's Extended Process Model of Emotion Regulation. The intervention includes four modules: (1) emotional identification and labeling, (2) emotional differentiation training, (3) emotion regulation strategy selection, and (4) implementation and reflective adaptation. Each session follows a cycle of emotional diary recording, labeling, feedback on emotional differentiation, and practice of regulation strategies. Participants are encouraged to complete at least two sessions per week. Predefined emotional categories and structured vocabulary support consistent labeling. Culturally adapted scenarios for young and middle-aged CRC survivors are included. Oncology nurses provide support, including clarification of emotional concepts, guidance on real-life application, and referral when needed
Otros nombres:
Routine psychological care will be provided by oncology nurses, along with standard educational materials on symptom management and basic emotional coping strategies consistent with clinical guidelines.
Participants will also complete the online questionnaires for outcome assessment.
|
|
Comparador activo: Control group
Participants in the control group will receive routine psychological care provided by oncology nurses.
|
Routine psychological care will be provided by oncology nurses, along with standard educational materials on symptom management and basic emotional coping strategies consistent with clinical guidelines.
Participants will also complete the online questionnaires for outcome assessment.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Recruitment Rate
Periodo de tiempo: During the recruitment period, up to 1 months
|
Recruitment rate will be defined as the proportion of eligible participants who consent to participate in the study.
|
During the recruitment period, up to 1 months
|
|
Retention Rate
Periodo de tiempo: Immediately post-intervention at 4 weeks
|
Retention rate will be defined as the proportion of enrolled participants who complete follow-up assessments at T1
|
Immediately post-intervention at 4 weeks
|
|
Adherence to the AI-Integrated Emotional Granularity Growth (AI-EGG) Program
Periodo de tiempo: Immediately post-intervention at 4 weeks
|
Adherence will be defined as the proportion of retained participants who complete all core intervention modules and at least 70% of Ecological Momentary Assessment (EMA) entries during the intervention period.
|
Immediately post-intervention at 4 weeks
|
|
Feasibility of Outcome Assessment
Periodo de tiempo: Immediately post-intervention at 4 weeks and 1-month post-intervention follow-up
|
Feasibility of outcome assessment will be evaluated based on the proportion of retained participants who successfully complete all required outcome assessments and follow-up interviews at T1 and T2.
|
Immediately post-intervention at 4 weeks and 1-month post-intervention follow-up
|
|
Ecological Momentary Assessment (EMA) Completion Rate
Periodo de tiempo: During the 4-week intervention period
|
EMA completion rate will be assessed as the proportion of completed EMA entries relative to the total number of expected EMA prompts during the intervention period.
|
During the 4-week intervention period
|
|
System Usability as Measured by the System Usability Scale (SUS)
Periodo de tiempo: Immediately post-intervention at 4 weeks
|
The System Usability Scale (SUS) is a 10-item questionnaire assessing perceived usability of the intervention platform.
Total scores range from 0 to 100, with higher scores indicating better usability.
|
Immediately post-intervention at 4 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Resilience Measured by the Chinese Version of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10)
Periodo de tiempo: Baseline (T0), immediately post-intervention at 4 weeks (T1), and 1-month post-intervention follow-up (T2)
|
The Chinese version of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10) is a 10-item self-report questionnaire assessing psychological resilience.
Each item is rated on a 5-point scale from 0 to 4. Total scores range from 0 to 40, with higher scores indicating greater resilience.
|
Baseline (T0), immediately post-intervention at 4 weeks (T1), and 1-month post-intervention follow-up (T2)
|
|
Quality of life Measured by the Chinese Version of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C)
Periodo de tiempo: Baseline (T0), immediately post-intervention at 4 weeks (T1), and 1-month post-intervention follow-up (T2)
|
The Chinese version of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C, Version 4) is a 36-item disease-specific quality-of-life questionnaire for colorectal cancer patients.
Each item is rated on a 5 point Likert scale from 0 ("not at all") to 4 ("very much") over the past 7 days, with higher scores indicating better quality of life.
|
Baseline (T0), immediately post-intervention at 4 weeks (T1), and 1-month post-intervention follow-up (T2)
|
|
Emotional granularity Measured by the Chinese Version of the Range and Differentiation of Emotional Experience Scale (RDEES)
Periodo de tiempo: Baseline (T0), immediately post-intervention at 4 weeks (T1), and 1-month post-intervention follow-up (T2)
|
The Chinese version of the Range and Differentiation of Emotional Experience Scale (RDEES) is an 11-item self-report scale assessing emotional granularity across two domains: range of emotional experience and emotional differentiation.
Total scores range from 11 to 55, with higher scores indicating greater emotional granularity.
|
Baseline (T0), immediately post-intervention at 4 weeks (T1), and 1-month post-intervention follow-up (T2)
|
|
Emotion Regulation Measured by the Chinese Version of the Difficulties in Emotion Regulation Scale (DERS)
Periodo de tiempo: Baseline (T0), immediately post-intervention at 4 weeks (T1), and 1-month post-intervention follow-up (T2)
|
The Chinese version of the Difficulties in Emotion Regulation Scale (DERS) is a 36-item self-report scale assessing multidimensional difficulties in emotion regulation.
Total scores range from 36 to 180, with higher scores indicating greater difficulties in emotion regulation.
|
Baseline (T0), immediately post-intervention at 4 weeks (T1), and 1-month post-intervention follow-up (T2)
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Accuracy of AI-Generated Emotion Identification at T1
Periodo de tiempo: Immediately post-intervention at 4 weeks (T1)
|
AI emotion recognition accuracy will be evaluated by comparing AI-generated emotion identification results with expert ratings.
Accuracy will be reported as the proportion of correctly identified emotional states.
|
Immediately post-intervention at 4 weeks (T1)
|
|
Participant Acceptability of AI-Integrated Emotional Granularity Growth (AI-EGG)
Periodo de tiempo: Immediately post-intervention (T1)
|
Participant acceptability, appropriateness, and perceived suitability of the intervention will be explored through semi-structured qualitative interviews conducted with a purposive subsample of intervention group participants.
|
Immediately post-intervention (T1)
|
Colaboradores e Investigadores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Neoplasias por sitio
- Neoplasias
- Enfermedades intestinales
- Neoplasias Gastrointestinales
- Neoplasias del Sistema Digestivo
- Enfermedades del Sistema Digestivo
- Enfermedades Gastrointestinales
- Neoplasias Intestinales
- Enfermedades Rectales
- Enfermedades del Colon
- Comportamiento
- Comportamiento social
- Autocontrol
- Neoplasias colorrectales
- Regulación Emocional
Otros números de identificación del estudio
- HSEARS20260427001
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Cáncer colorrectal (CCR)
-
Cancer Institute and Hospital, Chinese Academy...ReclutamientoCáncer Colorrectal (dMMR/MSI-H CRC)Porcelana
-
Stingray TherapeuticsReclutamientoCáncer colorrectal estable con microsatélites metastásico refractario (MSS-CRC)Estados Unidos
-
The First Affiliated Hospital with Nanjing Medical...Aún no reclutandoCáncer colorrectal metastásico irresecable | Cáncer colorrectal (CRC) estable en microsatélites (MSS) | Cáncer colorrectal con mutación RAS
-
Guangdong Provincial People's HospitalDesconocidoCáncer colonrectal | Metástasis hepática potencialmente resecable de CRCPorcelana
-
Check-Cap Ltd.TerminadoSujetos de alto riesgo (por encima del promedio) | Pacientes que no cumplen con la prueba de detección del cáncer colorrectal [CRC] | Pacientes contraindicados para colonoscopiaIsrael
-
Allegheny Singer Research Institute (also known...ReclutamientoCáncer gástrico | Cáncer de esófago | Adenocarcinoma gástrico | Carcinoma peritoneal | Cáncer de hígado | Cáncer peritoneal | Neoplasias Gástricas | Metástasis peritoneales | MSI-H | Metástasis hepática | SMS | MSS-CRCEstados Unidos
-
Istanbul Aydın UniversityTerminado
-
Abramson Cancer Center of the University of PennsylvaniaTerminadoPaciente con cancerEstados Unidos
-
University of Colorado, DenverGenentech, Inc.Activo, no reclutandoCáncer colorrectal Etapa IV | Cáncer colorrectal metastásico (CCR) | Cáncer colorrectal (CRC) estable en microsatélites (MSS)Estados Unidos
-
Peking Union Medical College HospitalTerminadoEncuesta | Estado nutricional | Paciente con cancerPorcelana
Ensayos clínicos sobre Emotional granularity training
-
Northwestern UniversityReclutamientoApnea obstructiva del sueño (AOS)Estados Unidos
-
Fenerbahce UniversityAcibadem Maslak HospitalAún no reclutandoCáncer pediátrico | Oncología Pediátrica | Catéter venoso central | Colocación de catéter venoso central | Infección del sitio de salida del catéter venoso centralTurquía (Türkiye)
-
Wuerzburg University HospitalReclutamientoPólipo colónico | Adenoma de colonAlemania
-
Ankara Etlik City HospitalReclutamientoOsteoartritis de rodilla | Entrenamiento de equilibrio | Rehabilitación Postoperatoria | Recuperación total de artroplastia de rodillaPavo
-
Rigshospitalet, DenmarkUniversity of CopenhagenTerminadoResultado de aprendizaje | Eficiencia de entrenamientoDinamarca
-
Diala BurjakTerminadoEducación estudiantil | La formación práctica | Educación en línea | Técnicas de sutura | Eficacia del entrenamientoJordán
-
Johns Hopkins Bloomberg School of Public HealthInnovations for Poverty Action; Investors Club/Enterprise UgandaTerminadoEstrés | Bienestar Psicológico | Dificultad económicaUganda
-
Columbia UniversityEinhorn CollaborativeTerminadoNacimiento prematuro | Trabajo de parto prematuro, obstétricoEstados Unidos
-
University of New HampshireAmerican Heart Association; California State University, San MarcosTerminadoModificación de la dieta | Ejercicio | Presión arterial | Promoción de la salud | Factor de riesgo cardiovascularEstados Unidos